Full history for every metric is available with a Kvantra account
Augmedix, Inc. (AUGX)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 11 | 14 | 16 | 22 | 31 | 45 | 52 |
| Operating profit | $m | -19 | -24 | |||||
| Net profit | $m | -24 | -22 | -15 | -17 | -27 | -19 | -24 |
| EPS reported | $ | -0.44 | -0.47 | |||||
| Operating cashflow per share | $ | -0.35 | -0.35 | |||||
| Capex per share | $ | 0.07 | 0.07 | |||||
| FCF per share | $ | -0.42 | -0.42 | |||||
| Free cash flow | $m | -19 | -18 | |||||
| Net debt | $m | -25 | -5 | |||||
| Book value equity | $m | 23 | 10 | |||||
| Book value per share | $ | 0.53 | 0.20 | |||||
| Number of shares | m | 43.95 | 53.39 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 11.02 | 11.07 | |||||
| P/S LTM | x | 5.73 | 2.25 | |||||
| P/FCF LTM | x | -13.86 | -6.49 | |||||
| EV/EBITDA LTM | x | -15.19 | -5.66 | |||||
| EV/Sales LTM | x | 5.31 | 2.15 | |||||
| Earnings Yield LTM | % | -7.46% | -18.60% | |||||
| FCF Yield | % | -7.21% | -15.42% | |||||
| Quality | ||||||||
| ROE | % | -82.20% | -154.69% | |||||
| ROIC | % | -36.76% | -36.76% | |||||
| Operating margin | % | -41.87% | -41.87% | |||||
| Gross margin | % | 47.99% | 47.99% | |||||
| FCF/Sales | % | -41.35% | -41.35% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +45.01% | +39.32% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.68 | -0.67 | |||||
| Net Debt/EBITDA | x | 1.21 | 1.21 | |||||
| EBIT/Net interest | x | -8.34 | -8.34 | |||||
| Net debt/market cap | % | -9.55% | -4.15% | |||||
| Net debt/Equity | x | -1.05 | -0.46 | |||||
| Gross debt/equity | x | 1.17 | 2.55 | |||||
Company overview
Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Augmedix, Inc. (AUGX)
Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free